Imagion Biosystems Limited Stock Performance
| IBXXF Stock | USD 0.04 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Imagion Biosystems are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Imagion Biosystems Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Imagion Biosystems is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 13.2 M | |
| Total Cashflows From Investing Activities | -310.1 K |
Imagion |
Imagion Biosystems Relative Risk vs. Return Landscape
If you would invest 3.50 in Imagion Biosystems Limited on September 15, 2024 and sell it today you would earn a total of 0.00 from holding Imagion Biosystems Limited or generate 0.0% return on investment over 90 days. Imagion Biosystems Limited is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Imagion, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Imagion Biosystems Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Imagion Biosystems' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Imagion Biosystems Limited, and traders can use it to determine the average amount a Imagion Biosystems' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| IBXXF |
Based on monthly moving average Imagion Biosystems is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Imagion Biosystems by adding Imagion Biosystems to a well-diversified portfolio.
Imagion Biosystems Fundamentals Growth
Imagion Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Imagion Biosystems, and Imagion Biosystems fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Imagion Pink Sheet performance.
| Return On Equity | -0.94 | |||
| Return On Asset | -0.44 | |||
| Operating Margin | (30.08) % | |||
| Current Valuation | 21.85 M | |||
| Shares Outstanding | 1.12 B | |||
| Price To Book | 3.16 X | |||
| Price To Sales | 60.01 X | |||
| Revenue | 232.87 K | |||
| EBITDA | (5.62 M) | |||
| Cash And Equivalents | 8.52 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 5.12 M | |||
| Debt To Equity | 0.62 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (5.07 M) | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 14.12 M | |||
About Imagion Biosystems Performance
By analyzing Imagion Biosystems' fundamental ratios, stakeholders can gain valuable insights into Imagion Biosystems' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Imagion Biosystems has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Imagion Biosystems has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. The company was incorporated in 2016 and is based in San Diego, California. Imagion Biosystems operates under Diagnostics Research classification in the United States and is traded on OTC Exchange.Things to note about Imagion Biosystems performance evaluation
Checking the ongoing alerts about Imagion Biosystems for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Imagion Biosystems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Imagion Biosystems generated a negative expected return over the last 90 days | |
| Imagion Biosystems has some characteristics of a very speculative penny stock | |
| Imagion Biosystems has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 232.87 K. Net Loss for the year was (6.02 M) with profit before overhead, payroll, taxes, and interest of 151.53 K. | |
| Imagion Biosystems Limited has accumulated about 8.52 M in cash with (5.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
- Analyzing Imagion Biosystems' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Imagion Biosystems' stock is overvalued or undervalued compared to its peers.
- Examining Imagion Biosystems' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Imagion Biosystems' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Imagion Biosystems' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Imagion Biosystems' pink sheet. These opinions can provide insight into Imagion Biosystems' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Imagion Pink Sheet analysis
When running Imagion Biosystems' price analysis, check to measure Imagion Biosystems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imagion Biosystems is operating at the current time. Most of Imagion Biosystems' value examination focuses on studying past and present price action to predict the probability of Imagion Biosystems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imagion Biosystems' price. Additionally, you may evaluate how the addition of Imagion Biosystems to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |